tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Arm Injuries D001134 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Orchitis D009920 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Meningitis, Fungal D016921 1 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dysuria D053159 1 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Akinetic Mutism D000405 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Ecthyma, Contagious D004474 1 associated lipids
Priapism D011317 1 associated lipids
Vulvar Lichen Sclerosus D007724 1 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Neurodermatitis D009450 1 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ichthyosiform Erythroderma, Congenital D016113 1 associated lipids
Panniculitis, Lupus Erythematosus D015435 1 associated lipids
Retrognathia D063173 1 associated lipids
Mediastinal Diseases D008477 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Leukemia, Myeloid, Chronic-Phase D015466 1 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Smooth Muscle Tumor D018235 1 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Poxviridae Infections D011213 1 associated lipids
Kaposi Varicelliform Eruption D007617 1 associated lipids
Lacerations D022125 1 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Tinea Capitis D014006 1 associated lipids
Digestive System Fistula D016154 1 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Leukoplakia, Oral D007972 1 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Rheumatoid Nodule D012218 1 associated lipids
Hernia, Ventral D006555 1 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Hearing Loss, Bilateral D006312 1 associated lipids
Nocturia D053158 1 associated lipids
Echinostomiasis D004451 1 associated lipids
Multiple Endocrine Neoplasia Type 2a D018813 1 associated lipids
Apraxias D001072 1 associated lipids
Hypertensive Encephalopathy D020343 1 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Rectal Diseases D012002 1 associated lipids
Citrullinemia D020159 1 associated lipids
Pulmonary Veno-Occlusive Disease D011668 1 associated lipids
Sweet Syndrome D016463 1 associated lipids
Optic Neuritis D009902 1 associated lipids
Granuloma Annulare D016460 1 associated lipids
Paraneoplastic Syndromes, Nervous System D020361 1 associated lipids
Intestinal Fistula D007412 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Nephritis, Hereditary D009394 1 associated lipids
Mastocytosis, Cutaneous D034701 1 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Lung Abscess D008169 1 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Facial Nerve Injuries D020220 1 associated lipids
Intertrigo D007402 1 associated lipids
Miller Fisher Syndrome D019846 1 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Mediastinal Emphysema D008478 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Eye Infections, Viral D015828 1 associated lipids
Dysplastic Nevus Syndrome D004416 1 associated lipids
Hypoplastic Left Heart Syndrome D018636 1 associated lipids
Mite Infestations D008924 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Armenti VT et al. Breastfeeding and tacrolimus: is it a reasonable approach? 2013 Expert Rev Clin Immunol pmid:23899232
Gómez-Bravo MA et al. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. 2013 J Clin Pharmacol pmid:23900887
Nakatani K [Personalized medicine in transplantation therapy]. 2013 Rinsho Byori pmid:23947183
Vassal O et al. [Bacterial parotitis in an immunocompromised patient in adult ICU]. 2013 Ann Fr Anesth Reanim pmid:23948025
Neto P et al. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report. 2013 Nefrologia pmid:23364650
Yoshikawa Y et al. [Pre-evening meal administration of tacrolimus improved refractory ocular symptoms in two young children with latent general myasthenia gravis]. 2013 No To Hattatsu pmid:23951946
Preidl RH et al. Clopidogrel reduces post-transplant obliterative bronchiolitis. 2013 Transpl. Int. pmid:23952051
Rabie R et al. Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis. 2013 Liver Transpl. pmid:22821730
Mignogna MD et al. Clinical behaviour and long-term therapeutic response in orofacial granulomatosis patients treated with intralesional triamcinolone acetonide injections alone or in combination with topical pimecrolimus 1%. 2013 J. Oral Pathol. Med. pmid:22784292
Nonaka K et al. Intractable membranous lupus nephritis showing selective improvement of subepithelial deposits with tacrolimus therapy: a case report. 2013 Clin. Nephrol. pmid:22541676
Nobuoka Y et al. Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay. 2013 Clin. Dev. Immunol. pmid:24454479
Akelma AZ et al. A diagnostic dilemma: inflammatory linear verrucous epidermal nevus versus linear psoriasis. 2013 J. Pediatr. pmid:23149170
Lemaitre F et al. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients. 2013 Clin. Biochem. pmid:23454394
Park JH et al. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. 2013 Photodermatol Photoimmunol Photomed pmid:23458396
Zuo XC et al. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis. 2013 Pharmacogenet. Genomics pmid:23459029
Boivin AA et al. Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients. 2013 Drug Metab. Pharmacokinet. pmid:23149872
van den Hoogen MW et al. Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study. 2013 Exp Clin Transplant pmid:23431996
Brown RS et al. Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report. 2013 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:23102802
van den Hoogen MW et al. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors. 2013 Exp Clin Transplant pmid:23432070
Westland T et al. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option? 2013 J Eur Acad Dermatol Venereol pmid:23106347
Du J et al. Long-term efficacy and safety of tacrolimus ointment in the treatment of vitiligo. 2013 J. Dermatol. pmid:24111918
Pan F et al. [Protective effect of tacrolimus postconditioning on oxidative stress injury provoked by spinal cord ischemia-reperfusion in rats]. 2013 Zhonghua Yi Xue Za Zhi pmid:24548402
Verma S et al. Preradial myxedema in a euthyroid male: A distinct rarity. 2013 Dermatol. Online J. pmid:24021369
Yosipovitch G et al. A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore. 2013 Int. J. Dermatol. pmid:22835263
Hirsch HH et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. 2013 Am. J. Transplant. pmid:23137180
Uchino M et al. Topical tacrolimus therapy for antibiotic-refractory pouchitis. 2013 Dis. Colon Rectum pmid:24022534
Lamoth F et al. In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. 2013 Antimicrob. Agents Chemother. pmid:23165466
de Jonge H et al. Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism. 2013 Pharmacogenomics pmid:24024898
Gijsen VM et al. CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. 2013 Pharmacogenomics pmid:23837477
Mesar I et al. Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity. 2013 Ren Fail pmid:24028307
Zhu Q et al. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. 2013 J. Pharm. Pharmacol. pmid:23837579
Shihab FS et al. Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. 2013 Am. J. Transplant. pmid:23167508
Dong QE et al. [Inhibitory effects of tacrolimus on effector T cells from patients with severe aplastic anemia]. 2013 Zhonghua Yi Xue Za Zhi pmid:24028719
Augusto JF et al. Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy. 2013 Ann. Transplant. pmid:23872516
Rojas LE et al. Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation. 2013 Pharmacogenet. Genomics pmid:23873120
Bourdeaux C et al. Prope tolerance after pediatric liver transplantation. 2013 Pediatr Transplant pmid:23171043
Jones AC et al. Phage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene cluster. 2013 PLoS ONE pmid:23874942
Prucha H et al. Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema. 2013 Expert Opin Drug Metab Toxicol pmid:23876065
Kim CH et al. 850nm light-emitting-diode phototherapy plus low-dose tacrolimus (FK-506) as combination therapy in the treatment of Dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice. 2013 J. Dermatol. Sci. pmid:23810774
Sapoznikov D et al. Heart rate response to blood pressure variations: sympathetic activation versus baroreflex response in patients with end-stage renal disease. 2013 PLoS ONE pmid:24124623
Rickels MR et al. Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. 2013 J. Clin. Endocrinol. Metab. pmid:24085506
Renner B et al. Cyclosporine induces endothelial cell release of complement-activating microparticles. 2013 J. Am. Soc. Nephrol. pmid:24092930
Rodríguez-Perálvarez M et al. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. 2013 J. Hepatol. pmid:23023010
Tadano T et al. [A case of calcineurin-inhibitor induced pain syndrome associated with tacrolimus therapy for ulcerative colitis]. 2013 Nihon Shokakibyo Gakkai Zasshi pmid:24097149
Faralli JA et al. Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway. 2013 Biochim. Biophys. Acta pmid:24100160
Michel S et al. Renal recovery after conversion to an everolimus-based immunosuppression in early and late heart transplant recipients: a 12-month analysis. 2013 Exp Clin Transplant pmid:24128136
Ciftci HS et al. Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. 2013 Transplant. Proc. pmid:23622581
Kim Y et al. Patients with persistent new-onset diabetes after transplantation have greater weight gain after kidney transplantation. 2013 J. Korean Med. Sci. pmid:24133345
Cotovio P et al. New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes. 2013 Transplant. Proc. pmid:23622631
Valente G et al. Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. 2013 Transplant. Proc. pmid:23622676
Landy J et al. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis--an analysis of outcomes in two London tertiary centres. 2013 J Crohns Colitis pmid:23623737
Vichyanond P and Kosrirukvongs P Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. 2013 Curr Allergy Asthma Rep pmid:23625179
Wang Y et al. Micelles of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) as a novel drug delivery vehicle for tacrolimus. 2013 J Biomed Nanotechnol pmid:23627041
Elens L et al. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. 2013 Pharmacogenet. Genomics pmid:24113216
Magalhaes OA et al. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study. 2013 Br J Ophthalmol pmid:24008822
Axelsson J et al. Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. 2013 Am. J. Physiol. Renal Physiol. pmid:23657856
Hung TC et al. Investigation of SSEA-4 binding protein in breast cancer cells. 2013 J. Am. Chem. Soc. pmid:23574147
Quaglia M et al. Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms. 2013 J Clin Pharm Ther pmid:23574377
Wang R et al. Systemic lupus erythematosus associated with Moyamoya syndrome: a case report and literature review. 2013 Lupus pmid:23574743
Karapetyan YE et al. Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23576755
Miyoshi J et al. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients. 2013 J Crohns Colitis pmid:23680174
Selden NR et al. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. 2013 J Neurosurg Pediatr pmid:23581634
Xia M et al. Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis. 2013 Biotechnol. Bioeng. pmid:23682004
Hill JA et al. Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. 2013 PLoS Genet. pmid:23593013
Lee Sr et al. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects. 2013 Kidney Blood Press. Res. pmid:23594830
Israni AK et al. Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics. 2013 Transpl. Int. pmid:23879408
Cristelli MP et al. Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids. 2013 Transpl Infect Dis pmid:23701592
Casanova JR et al. Rapid hippocampal network adaptation to recurring synchronous activity--a role for calcineurin. 2013 Eur. J. Neurosci. pmid:23879713
Siegfried EC et al. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. 2013 Am J Clin Dermatol pmid:23703374
Huang D et al. Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement. 2013 Microb. Cell Fact. pmid:23705993
Ban YH et al. Characterization of FK506 biosynthetic intermediates involved in post-PKS elaboration. 2013 J. Nat. Prod. pmid:23706030
Pamuk F et al. Effects of tacrolimus and nifedipine, alone or in combination, on gingival tissues. 2013 J. Periodontol. pmid:23289868
Eguchi R et al. FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. 2013 Cell. Signal. pmid:23707520
Fitzgerald RT et al. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome. 2013 Pediatr. Neurol. pmid:23290027
van Maarseveen EM et al. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. 2013 Transplantation pmid:23250333
Han N et al. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients. 2013 Eur. J. Clin. Pharmacol. pmid:22660440
Oteo I et al. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction. 2013 Eur. J. Clin. Pharmacol. pmid:22660442
Valdivieso N et al. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology. 2013 Int J Clin Pharmacol Ther pmid:23735178
Zhou X et al. A genome-wide screening of potential target genes to enhance the antifungal activity of micafungin in Schizosaccharomyces pombe. 2013 PLoS ONE pmid:23738021
Bashratyan R et al. Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice. 2013 Eur. J. Immunol. pmid:23817982
Hebert MF et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. 2013 Transplantation pmid:23274970
Chitnis SD et al. Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. 2013 Xenobiotica pmid:23278282
Bunnapradist S et al. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. 2013 Am. J. Transplant. pmid:23279614
Zlatic SA et al. Chemical-genetic disruption of clathrin function spares adaptor complex 3-dependent endosome vesicle biogenesis. 2013 Mol. Biol. Cell pmid:23761069
Ceschi A et al. Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. 2013 Am. J. Transplant. pmid:23279718
Yin H et al. Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. 2013 PLoS ONE pmid:23762423
Böer TM et al. Correlation of thermal analysis and pyrolysis coupled to GC-MS in the characterization of tacrolimus. 2013 J Pharm Biomed Anal pmid:22361660
López E et al. FKBP52 is involved in the regulation of SOCE channels in the human platelets and MEG 01 cells. 2013 Biochim. Biophys. Acta pmid:23228564
Tie X et al. NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells. 2013 PLoS ONE pmid:23762456
Bootun R Effects of immunosuppressive therapy on wound healing. 2013 Int Wound J pmid:22364410
Fujita Y et al. Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents. 2013 J Clin Pharm Ther pmid:22971159
Sharma P and Barman P Everolimus for liver transplant recipients: is it ready for prime time? 2013 Gastroenterology pmid:23260492
Sofue T et al. Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients. 2013 Clin. Exp. Nephrol. pmid:23269423
Inoue T et al. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy. 2013 Intern. Med. pmid:23291669
Tanaka Y et al. [Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. 2013 Yakugaku Zasshi pmid:23328499
Wong R and Lin AN Efficacy of topical calcineurin inhibitors in vitiligo. 2013 Int. J. Dermatol. pmid:23331250
Loar RW et al. Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient. 2013 Pediatr Transplant pmid:23331314
Mori T et al. Effective treatment of a 13-year-old boy with steroid-dependent ocular myasthenia gravis using tacrolimus. 2013 Brain Dev. pmid:22840813
Barbas AS et al. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. 2013 Am. J. Transplant. pmid:23331705
Rice SA et al. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. 2013 BMC Res Notes pmid:23331739